Congenital heart diseaseCohort study

Non-invasive biomarkers of liver disease as prognostic indicators in patients with Fontan circulation

HeartPublished

  • retrospective observational cohort study
  • large-volume adult congenital heart disease centre

Authors' conclusion

Higher FibroSURE, APRI, FIB-4 and MELD-XI are associated with increased hazard of death or transplant in Fontan circulation.

Study context

Population
Adults with Fontan circulation who had FibroSURE testing between 2008 and 2022adults with Fontan circulation, 664 FibroSURE results
Participants
334 adults
Exposure
FibroSURE score, Aminotransferase-to-Platelet Ratio Index (APRI), FIB-4 and MELD-XI analysed against death or transplant

Main finding

As reported in the abstract

FibroSURE results above the nominal cut-off predicting cirrhosis (>0.74) · study period

FibroSURE results above cut-off (>0.74), of 664 results

83 (13%)

Observational data: associations, not effects.

Further findings

Death or transplant, in 314 patients with all four scores available

ComparisonHR (95% CI)P value
FibroSURE >0.745.11 (2.66–9.83)P < 0.001
APRI >0.52.56 (1.36–4.81)P = 0.004
FIB-4 >1.455.07 (2.67–9.64)P < 0.001
MELD-XI >1824.1 (5.51–106)P < 0.001
Outcomefold increased hazard (95% CI)P value
Death or transplant — each 0.1 increase in FibroSURE score · adjusted for age at FibroSURE and history of hepatitis C1.19 (1.02–1.40)P = 0.032
Death or transplant — FibroSURE >0.74 · adjusted for age at FibroSURE and history of hepatitis C3.26 (1.62–6.59)P = 0.001
  • Death or transplant, in 314 patients with all four scores available: n=314

Deaths and transplants · median follow-up of 5.6 years (IQR 2.7-9.9)

Deaths
37 deaths (11%)
Transplants
four transplants (1%)

Original publication

Non-invasive biomarkers of liver disease as prognostic indicators in patients with Fontan circulation. Heart. Published 30 January 2026. doi:10.1136/heartjnl-2025-327308

Summarised from the published abstract; every number is checked against it